March 14, 2016

Stocks In News - USFDA

USFDA
Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate rablets, 2.5 mg
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)